Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine neurodegeneration

Neurosci Lett. 2001 Aug 31;309(3):145-8. doi: 10.1016/s0304-3940(01)02064-x.

Abstract

Dentatorubral-pallidoluysian atrophy (DRPLA) is a neurodegenerative disease that results from the expansion of an unstable CAG repeat within the coding regions of the DRPLA gene. Recently it was shown that the DRPLA gene product, atrophin-1, interacts with the human insulin receptor tyrosine kinase substrate protein, IRSp53. We have isolated rat and mouse cDNA clones for IRSp53 and determined expression patterns in rat central nervous system. In situ hybridization analysis revealed enriched IRSp53 mRNA expression in rat forebrain structures, including the cerebral cortex (layers II/III, V and VI), striatum, hippocampus and olfactory bulb. IRSp53 hybridization signals were also detected in the cerebellum, subthalamic nucleus, pons, amygdala and hypothalamus. These findings support the idea that insulin and insulin growth factor-1 have a role in neurotransmission, one that is regionally specific. The expression of IRSp53 in regions similar to those that degenerate in DRPLA supports the notion that IRSp53 is a relevant atrophin-1 binding protein and may provide a mechanism for region-specific neurodegeneration.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cerebral Cortex / metabolism*
  • Corpus Striatum / metabolism*
  • Humans
  • Male
  • Mice
  • Myoclonic Epilepsies, Progressive / metabolism
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / metabolism*
  • Neurodegenerative Diseases / metabolism*
  • Neurons / metabolism*
  • Peptides / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • BAIAP2 protein, human
  • Baiap2 protein, mouse
  • Nerve Tissue Proteins
  • Peptides
  • RNA, Messenger
  • atrophin-1
  • polyglutamine